Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 5, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 5, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 4, 2011View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionApr 29, 2011View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventApr 28, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 26, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 20, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 15, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 15, 2011View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GApr 8, 2011View HTMLDownload DOCDownload PDF
ARSAn annual report to security holders.Apr 4, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 4, 2011View HTMLDownload DOCDownload PDF
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Mar 29, 2011View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveMar 29, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 23, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 11, 2011View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Mar 11, 2011View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMar 8, 2011View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 2, 2011View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 24, 2011View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-115

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information